Fourteen patients met inclusion criteria. Six patients had congenital facial palsy and 8 patients had acquired. The average age at time of surgery was 10.3 ± 4.4 years for congenital and 14.0 ± 5.7 years for acquired etiology (p=0.20) Causes of congenital disease included idiopathic (5) and birth trauma (1). Causes for acquired facial palsy were tumor resection (5), meningitis (1), and trauma (2). On univariate analysis, surface EMG scores averaged 55.36 for congenital patients and 33.63 for acquired patients (p=0.01). Using a mixed regression model that controlled for sex, age and time after surgery, there was no significant difference between congenital and acquired subjects in surface EMG measurements, open smile Sunnybrook scores, or total Sunnybrook scores (p=0.23, 0.88, and 0.52; respectively). However, a mixed regression model was used to analyze data from FACE-gram. Patients with acquired facial palsy, relative to congenital, had an average difference of 7.08 +/-2.99 mm in overall commissure displacement when comparing paralyzed to unaffected side over time. (p=0.018).
CONCLUSION:
When comparing congenital versus acquired etiologies, our results demonstrate that there is no significant difference in post-operative Sunnybrook scores or muscle activity for patients who have undergone two-stage CFNG-FGMT; however, it appears that by objective measurement using FACE-gram there is a greater degree of persistent asymmetry in patients with acquired facial palsy after dynamic two-stage reconstruction. 
RESULTS:
Five patients with LTM and 14 with CFNG-FGMT were identified. The average age at time of surgery was 14.3 ± 5.7 years for LTM and 12.4 ± 5.4 years for CFNG-FGMT (p=0.41). There was no difference in number of treatment sessions between LTM and CFNG-FGMT patients (9.0 ± 4.9 vs. 10.3 ± 11.8, p=0.661). Significant muscle activity was first identified in LTM patients after 3 months (44.4 ± 12.2mV, p<0.001) and CFNG-FGMT patients after 2 months (38.3 ± 17.4mV, p=0.028). Beta-coefficient regression revealed a steeper slope of increase in sEMG in LTM compared to CFNG-FGMT patients (9.2mV/month versus 2.3mV/ month, respectively). CFNG-FGMT patients exhibited a 17.0 ± 5.9 Sunnybrook score increase at the 6-9 month interval relative to the first three months after surgery (p=0.004). Sunnybrook scores were not different between LTM and CFNG-FGMT patients when assessed for interval increase (p=0.905) CONCLUSION: Facial reanimation outcomes can be reliably assessed with sEMG and Sunnybrook scores. LTM demonstrates a faster rate of muscle recruitment compared to CFNG. Both LTM and CFNG-FGMT demonstrate muscle activity at 2-3 months. Facial symmetry by Sunnybrook score improves at 6-9 months postoperatively.
